Description
Revised details for takeover offer of Vilin Bio Med Limited with updated security parameters and offer period from September 1-15, 2025.
Summary
NSE has issued revised details for the takeover offer of Vilin Bio Med Limited under the Tender Offer scheme. This circular modifies the earlier circular dated August 22, 2025, and provides updated security parameters for the offer period from September 1-15, 2025 (excluding September 8, 2025).
Key Points
- Takeover offer for up to 36,27,000 equity shares of Vilin Bio Med Limited
- Offer price fixed at Rs. 23.40 per share with face value of Rs. 10
- Eight acquirers involved including Mr. Allu Rama Krishna Reddy and associates
- Lot size of 4000 equity shares with ISIN INE0L4V01013
- Order modification and cancellation not permitted for takeover offers
- Multiple bidding categories available for different investor types
Regulatory Changes
This circular provides revised security parameters from the earlier circular NSE/CMTR/69802 dated August 22, 2025. The offer follows the Tender Offer Scheme Exchange circular NSE/CMTR/52776 dated June 29, 2022.
Compliance Requirements
- All trading must follow the Tender Offer Scheme guidelines
- Order modification (quantity) and cancellation are not permitted
- AFCO Capital India Private Limited appointed as Merchant Banker
- Bigshare Services Private Limited appointed as Registrar
- Different status codes apply for various investor categories (FII, MF, IC, FI, OTH, CO, IND, NOH)
Important Dates
- Offer Period: September 1, 2025 to September 15, 2025
- Excluded Date: September 8, 2025 (no trading)
- Circular Date: September 4, 2025
- Reference Circular: August 22, 2025
Impact Assessment
The takeover offer directly impacts Vilin Bio Med Limited shareholders who can participate in the tender offer at the fixed price of Rs. 23.40 per share. The offer provides an exit opportunity for shareholders at a predetermined price, with specific procedures and restrictions in place to ensure orderly execution of the takeover process.
Impact Justification
Takeover offer affects specific company shareholders with defined timelines and procedures